Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and Further Reading
Al-Essa M, Bakheet SM, Patay ZJ, Nounou RM, Ozand TP. Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile Gm1 gangliosidosis. Brain Dev 1999; 21: 559–562
Beratis NG, Varvarigou-Frimas A, Beratis S, Sklower SL. Angiokeratoma corporis diffusum in GM1 gangliosidosis, type 1. Clin Genet 1989; 36: 59–64
Cabral A, Portela R, Tasso T, Eusebio F, Moreira A, Marques dos Santos H, Soares J, Moura-Nunes JF. A case of GM1 gangliosidosis type I. Ophthalmic Paediatr Genet 1989; 10: 63–67
Callahan JW. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein. Biochim Biophys Acta 1999; 1455; 85–103
Chen CY, Zimmerman RA, Lee CC, Chen FH, Yuh YS, Hsiao HS. Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR Am J Neuroradiol 1998; 19: 1628–1630
Folkerth RD, Alroy J, Bhan I, Kaye EM. Infantile Gm1 gangliosidosis: complete morphology and histochemistry of two autopsied cases, with particular reference to delayed central nervous system myelination. Pediatr Dev Pathol 2000; 3: 73–86
Gascon GG, Ozand PT, Erwin RE. GM1 Gangliosidosis type 2 in two siblings. J Child Neurol 1992; 7: S41–S50
Goebel HH. Morphology of the gangliosidoses. Neuropediatrics 1984; 15: 97–106
Guazzi GC, D’Amore I, van Hoof F, Fruschelli C, Alessandrini C, Palmeri S, Federico A. Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sisters. Neurology 1988; 38: 1124–1127
Hinek A, Zhang S, Smith AC, Callahan JW. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of β-galactosidase. Am J Hum Genet 2000; 67: 23–36
Inui K, Namba R, Ihara Y, Nobukuni K, Taniike M, Midorikawa M, Tsukamoto H. A case of chronic GM1 gangliosidosis presenting as dystonia: clinical and biochemical studies. J Neurol 1990; 237: 491–493
Kasama T, Taketomi T. Abnormalities of cerebral lipids in GM1-gangliosidoses, infantile, juvenile, and chronic type. Jpn J Exp Med 1986; 56: 1–11
Kaye EM, Alroy J, Raghavan SS, Schwarting GA, Adelman LS, Runge V, Gelblum D, Johann G, Thalhammer DVM, Zuniga G. Dysmyelinogenesis in animal model of GM1 gangliosidosis. Pediatr Neurol 1992; 8: 255–261
Kobayashi T, Suzuki K. Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies. Ann Neurol 1981; 9: 476–483
Kobayashi O, Takashima S. Thalamic hyperdensity on CT in the infantile GM1-gangliosidosis. Brain Dev 1994; 16: 472–474
Kohlschütter A. Clinical course of GM1 gangliosidoses. Neuropediatrics 1984; 15: 71–73
Lin H-C, Tsai F-J, Shen C-H, Peng C-T. Infantile form Gm1 gangliosidosis with dilated cardiomyopathy: a case report. Acta Paediatr 2000; 89: 880–883
Morrone A, Bardelli T, Donati MA, Giorgi M, di Rocco M, Gatti R, Parini R, Ricci R, Tadeucchi G, D’Azzo A, Zammarchi E. β-Galactosidase gene mutations affecting the lysosomal enzyme and the elasin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat 2000; 15: 354–366
Nardocci N, Bertagnolio B, Rumi V, Combi M, Bardelli P, Angelini L. Chronic GM1 gangliosidosis presenting as dystonia: clinical and biochemical studies in a new case. Neuropediatrics 1993; 24: 164–166
O’Brien JS, Storb R, Raff RF, Harding J, Appelbaum F, Morimoto S, Kishimoto Y, Graham T, Ahern-Rindell A, O’Brien SL. Bone marrow transplantation in canine GM1 gangliosidosis. Clin Genet 1990; 38: 274–280
Pampiglione G, Harden A. Neurophysiological investigations in GM1 and GM2 gangliosidoses. Neuropedatrics 1984; 15: 74–84
Sandhoff K, Conzelmann E. The biochemical basis of gangliosidoses. Neuropediatrics 1984; 15: 85–92
Shen W-C, Tsai FJ, Tsai C-H. Myelination arrest demonstrated using magnetic resonance imaging in a child with type GM1 gangliosidosis. J Formos Med Assoc 1998; 97: 296–299
Silva CMD, Severini MH, Sopelsa A, Coelho JC, Zaha A, d’Azzo A, Giugliani R. Six novel β-galactosidase gene mutations in Brazilian patients with GM1-gangliosidosis. Hum Mutat 1999; 13: 401–409
Suzuki K, Suzuki K, Chen GC. Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 1968; 27: 15–38
Suzuki K, Suzuki K, Kamoshita S. Chemical pathology of GM1 gangliosidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 1969; 28: 25–73
Suzuki Y, Sakuraba H, Oshima A, Yoshida K, Shimmoto M, Takano T, Fukuhara Y. Clinical and molecular heterogeneity in hereditary β-galactosidase deficiency. Dev Neurosci 1991; 13: 299–303
Tanaka R, Momoi T, Yoshida A, Okumura M, Yamakura S, Takasaki Y, Kiyomasu T, Yamanaka C. Type 3 GM1 gangliosidosis: clinical and neurological findings in an 11-year-old girl. J Neurol 1995; 242: 299–303
Tominaga L, Ogawa Y, Taniguchi M, Ohno K, Matsuda J, Oshima A, Suzuki Y, Nanba E. Galactonojirimycin derivatives restore mutant human β-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse. Brain Dev 2001; 23: 284–287
Urban Z, Boyd CD. Elastic-fiber pathologies: primary defects in assembly — and secondary disorders in transport and delivery. Am J Hum Genet 2000; 67: 4–7
Uyama E, Terasaki T, Watanabe S, Naito M, Owada M, Araki S, Ando M. Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. Acta Neurol Scand 1992; 86: 609–615
van der Voorn JP, Kamphorst W, van der Knaap MS, Powers JM. The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction. Acta Neuropathol (Berl) 2004; 107: 539–545
Walkley SU, Baker HJ, Rattazzi MC, Haskins ME, Wu JY. Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement. J Neurol Sci 1991; 104: 1–8
Wood PA, McBride MR, Baker HJ, Christian ST. Fluorescence polarization analysis, lipid composition, and Na+, K+-ATPase kinetics of synaptosomal membranes in feline GM1 and GM2 gangliosidosis. J Neurochem 1985; 44: 947–956
Yoshida K, Oshima A, Sakuraba H, Nakano T, Yanagisawa N, Inui K, Okada S, Uyama E, Namba R, Kondo K, Iwasaki S, Takamiya K, Suzuki Y. GM1 gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients. Ann Neurol 1992; 31: 328–332
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2005). GM1 Gangliosidosis. In: Magnetic Resonance of Myelination and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27660-2_9
Download citation
DOI: https://doi.org/10.1007/3-540-27660-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22286-6
Online ISBN: 978-3-540-27660-9
eBook Packages: MedicineMedicine (R0)